0179-0096 : Rescriptor 200 mg Oral Tablet
NDC: | 0179-0096 |
Labeler: | Kaiser Foundation Hospitals |
Product Type: | Human Prescription Drug |
Drug Name: | Rescriptor |
Dosage Form: | Oral Tablet |
Application #: | NDA020705 |
Rev. Date: |
Appearance:
Markings: | RESCRIPTOR;200;mg |
Shapes: |
Oval |
Colors: |
White |
Size (mm): | 17 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 0179-0096-70: 30 TABLET IN 1 BOX, UNIT‑DOSE (0179‑0096‑70)
Active Ingredients:
- Delavirdine Mesylate
Dosage Strength:
- 200 mg
Inactive Ingredients:
- Carnauba Wax
- Silicon Dioxide
- Croscarmellose Sodium
- Anhydrous Lactose
- Magnesium Stearate
- Cellulose, Microcrystalline
- Hypromelloses
Pharmaceutical Classes:
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Non-Nucleoside Analog [Chemical/Ingredient]
- Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 49702-209 Rescriptor 100 mg Oral Tablet by Viiv Healthcare Company
- 49702-210 Rescriptor 200 mg Oral Tablet by Viiv Healthcare Company
- 49702-225 Rescriptor 200 mg Oral Tablet by Viiv Healthcare Company
- 63010-020 Rescriptor 100 mg Oral Tablet by Pharmacia and Upjohn Company
- 63010-021 Rescriptor 200 mg Oral Tablet by Pharmacia and Upjohn Company
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0179-0095Next: 0179-0098 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.